Mark Greene
Founding Director, Cancer and Immunobiology Division · University of Pennsylvania Health System
Credentials: · · ·
History
1976–1978- 1976–1977
- 1975–1976
Health Sciences Centre
- 1973–1975
Medical Research Council Fellowship
- 1968–1972
- 1965–1968
Research
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
Nature · 1984 · 1,139 citations
Deacetylase inhibition promotes the generation and function of regulatory T cells
Nature Medicine · 2007 · 778 citations
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer
Nature Immunology · 2008 · 644 citations
- BB
38 papers
- WW
30 papers
- JD
27 papers · 6 as a resident
18 papers · 7 as a fellow
12 papers
12 papers
11 papers · 3 as a resident
10 papers · 1 as a resident
Grants
- 2018–2025
Immunologic Aspects of Targeted Therapy of erbB Tumors
National Cancer Institute · R01
Contact PI · $1.8M · University of Pennsylvania
- 2018–2021
The Role of Post-Translational Modifier PRMT5 in Regulatory T Cell Development and Function
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $442.8K · University of Pennsylvania
- 2012–2017
Carbohydrate Antigenic Biomarkers for Epithelial Cancers
National Cancer Institute · U01
Contact PI · $1.4M · University of Pennsylvania
- 2001–2016
Receptor Mediated Breast Cancer Therapy
National Cancer Institute · R01
Contact PI · $3.3M · University of Pennsylvania
Clinical trials
- 2008
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
Principal investigator · Withdrawn
Gynecologic Oncology Group